talinolol Report issue

Small molecule Experimental
AACT ChEMBL DrugBank Drug Central KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now
Talinolol is a beta blocker.   Wikipedia

Chemistry

  • SMILES: CC(C)(C)NCC(O)COc1ccc(NC(=O)NC2CCCCC2)cc1
  • InChIKey: MXFWWQICDIZSOA-UHFFFAOYSA-N
  • Mol. Mass: 363.5
  • ALogP: 3.27
  • ChEMBL Molecule:
    talinolol  
More Chemistry

Pharmacology

Alternative names

1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane | cordanum | (+-)-n-cyclohexyl-n'-(4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)urea | racemic talinolol | talinolol | (+/-)-talinolol | talinolol acetate | talinolol benzoate | talinolol hydrochloride | talinolol, (+-)-isomer | talinolol monoacetate | talinolol monohydrochloride | talinolol mononitrate | talinolol monosalicylate | talinolol nitrate | talinolol oxalate | talinolol oxalate (2:1) | talinolol salicylate | talinolol sulfate | talinolol sulfate (2:1) | talinolol tartrate (2:1), l-(+)-isomer | talinolol tartrate, l-(+)-isomer

Organizations (3)

Research & Development (3)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (5)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (5)


 

Intestinal Neoplasms (Phase 1)

Metabolism (Phase 1)

Obesity, Morbid (Phase 1)

Pharmacology (Phase 1)

Sports Medicine (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 4
  • # of Trial Organizations: 3

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue